Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Cancers|June 27, 2024
Shifting from Immunohistochemistry to Screen for <i>ALK</i> Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung CancerMarius Ilié, Samantha Goffinet, Guylène Rignol, et al.
Journal of Translational Medicine|February 19, 2020
Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institutionSimon Heeke, Véronique Hofman, Marius Ilié, et al.
International Journal of Molecular Sciences|July 14, 2023
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical PracticeArnaud Martel, Baharia Mograbi, Barnabe Romeo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1<sup>+</sup> and CD8<sup>+</sup> tumor-infiltrating T cells and outcomeMarius Ilie, Alexander T Falk, Catherine Butori, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph NodesElodie Long-Mira, Alexandra Picard-Gauci, Sandra Lassalle, et al.
Annales De Pathologie|March 12, 2013
[Accreditation of the activity of molecular pathology according to ISO 15189: key steps to follow and the main potential pitfalls]Elodie Long, Véronique Hofman, Marius Ilie, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2020
Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France)Véronique Hofman, Jonathan Benzaquen, Simon Heeke, et al.
Annales De Pathologie|November 9, 2010
[The Nice CHU biobank experience to collect patients' informed consent for research context (2004-2009)]Véronique Hofman, Christelle Bonnetaud, Marie Clotilde Gaziello, et al.
Oncotarget|December 15, 2018
Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patientsElodie Long-Mira, Marius Ilie, Emmanuel Chamorey, et al.
Cancers|April 17, 2020
Targeted Assessment of the <i>EGFR</i> Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)Sandra Lassalle, Véronique Hofman, Simon Heeke, et al.
Pageof 5